Sulukoğlu, E. K. Et Al. 2024. Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1. Naunyn-Schmiedeberg's Archives of Pharmacology , vol.397, no.8 , 5745-5755.

Sulukoğlu, E. K., Günaydın, Ş., Kalın, Ş. N., ALTAY, A., & BUDAK, H., (2024). Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1. Naunyn-Schmiedeberg's Archives of Pharmacology , vol.397, no.8, 5745-5755.

Sulukoğlu, Emine Et Al. "Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1," Naunyn-Schmiedeberg's Archives of Pharmacology , vol.397, no.8, 5745-5755, 2024

Sulukoğlu, Emine K. Et Al. "Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1." Naunyn-Schmiedeberg's Archives of Pharmacology , vol.397, no.8, pp.5745-5755, 2024

Sulukoğlu, E. K. Et Al. (2024) . "Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1." Naunyn-Schmiedeberg's Archives of Pharmacology , vol.397, no.8, pp.5745-5755.

@article{article, author={Emine Karaca Sulukoğlu Et Al. }, title={Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1}, journal={Naunyn-Schmiedeberg's Archives of Pharmacology}, year=2024, pages={5745-5755} }